2022
DOI: 10.1016/j.molmet.2022.101602
|View full text |Cite
|
Sign up to set email alerts
|

Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
29
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(38 citation statements)
references
References 91 publications
(154 reference statements)
8
29
1
Order By: Relevance
“…Moreover, this study found that both TC and TG were elevated in the liver after GenX exposure, as confirmed by previously published literature. , But changes in TG and TC in plasma were not consistent, with no change in TG and an increase in TC with increasing GenX dose. Interestingly, our study was broadly similar to the population study, which found that serum TC was proportional but not linearly related to GenX concentration, whereas TG was not correlated with GenX concentration …”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…Moreover, this study found that both TC and TG were elevated in the liver after GenX exposure, as confirmed by previously published literature. , But changes in TG and TC in plasma were not consistent, with no change in TG and an increase in TC with increasing GenX dose. Interestingly, our study was broadly similar to the population study, which found that serum TC was proportional but not linearly related to GenX concentration, whereas TG was not correlated with GenX concentration …”
Section: Discussionsupporting
confidence: 88%
“…Probably the experimental gradients used in our experiments span a wide range, and the substance may have different toxic effects at different concentration doses. GenX, as an alternative to PFOA, may have similar toxic effects to PFOA, and previous studies have shown that there is no linear relationship between the liver damage of PFOA at different concentration gradients . There are many substances that may indeed cause different toxic effects at different concentrations.…”
Section: Discussionmentioning
confidence: 99%
“…Following Trp degradation, a portion of Kyn is ultimately converted to NAD through the 3-HAA pathway, while another fraction is converted to KA. , As an important site for Kyn pathway, the liver is responsible for 90% of Trp degradation under normal physiological conditions. , Previous study has confirmed that increase of KATs expression in skeletal muscle can be induced by selective PPARα agonists only under PGC-1α overexpression . In mice liver, although HFPO-DA can activate PPARα, ,, it results in down-regulation of PGC-1α mRNA levels, which may explain the decreased KATs expression and reduced KA observed in HFPO-DA treated mice in this study. In addition, studies by Gonzalez and Yue et al have revealed that Wy-14,643, a selective PPARα agonist, only disturbs the nicotinamide-NAD pathway and not the Kyn pathway, suggesting that the effect of HFPO-DA on the hepatic Kyn pathway may not be not a consequence of PPAR activation.…”
Section: Discussionmentioning
confidence: 96%
“…11 Most PFAS hepatic toxicity is thought to be mediated by PPARα, since PPARα knockout in mice reduces the outcomes of PFOS and GenX (an alternative PFAS substance). 12 In our previous study, through in vitro binding assays, we found that perfluoroalkyl carboxylates (PFCAs) and perfluoroalkyl sulfonates (PFSAs) with various numbers of perfluorinated carbons directly bind to human PPARα and that a variety of PFAS may induce adverse effects through PPARα in humans. 13 To screen for PFAS that induce adverse effects via PPARα, it is necessary to determine the binding affinities between PPARα and various PFAS.…”
Section: Introductionmentioning
confidence: 99%
“…As PFAS are organofluorine analogs of fatty acids (the endogenous ligand for PPARα), binding and activation of PPARα is a logical molecular-initiating event in lipid destruction . Most PFAS hepatic toxicity is thought to be mediated by PPARα, since PPARα knockout in mice reduces the outcomes of PFOS and GenX (an alternative PFAS substance) . In our previous study, through in vitro binding assays, we found that perfluoroalkyl carboxylates (PFCAs) and perfluoroalkyl sulfonates (PFSAs) with various numbers of perfluorinated carbons directly bind to human PPARα and that a variety of PFAS may induce adverse effects through PPARα in humans …”
Section: Introductionmentioning
confidence: 99%